Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Chen, ZhiGuo  [Clear All Filters]
Journal Article
Zhao Y, Liu Z, Wang X, Wu H, Zhang J, Yang J, Zhang F, Liu L, Long J, Lu P, et al. Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies. Clin Cancer Res. 2019.
Li M, Wang X, Qi B, Cui S, Zheng T, Guan Y, Ma L, Liu S, Li Q, Chen ZG, et al. Treatment of Syringomyelia Characterized by Focal Dilatation of the Central Canal Using Mesenchymal Stem Cells and Neural Stem Cells. Tissue Eng Regen Med. 2024.
Liu S, Liu B, Li Q, Zheng T, Liu B, Li M, Chen ZG. Transplantation of fibrin-thrombin encapsulated human induced neural stem cells promotes functional recovery of spinal cord injury rats through modulation of the microenvironment. Neural Regen Res. 2024;19(2):440-446.
Liu W, Zhao Y, Liu Z, Zhang G, Wu H, Zheng X, Tang X, Chen ZG. Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK. Cell Oncol (Dordr). 2023.
Wood B, Devidas M, Summers RJ, Chen ZG, Asselin BL, Rabin KR, Zweidler-McKay PA, Winick NJ, Borowitz MJ, Carroll WL, et al. Prognostic Significance of ETP Phenotype and Minimal Residual Disease in T-ALL: A Children's Oncology Group Study. Blood. 2023.
Tan K, Xu J, Chen C, Vincent T, Pölönen P, Hu J, Yoshimura S, Yu W, Sussman J, Chen C-H, et al. Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia. Res Sq. 2023.
Mo J, Anastasaki C, Chen ZG, Shipman T, Papke JB, Yin KY, Gutmann DH, Le LQ. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins. J Clin Invest. 2020.
Ma D, Zhang H, Yin L, Xu H, Wu L, Shaji R, Rezai F, Mulla A, Kaur S, Tan S, et al. Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway. Glia. 2023.
Li Q, Liu S, Zheng T, Li M, Qi B, Zhou L, Liu B, Ma D, Zhao C, Chen ZG. Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury. Stem Cell Res Ther. 2024;15(1):35.
Zhang Q, Chen ZG, Zhang K, Zhu J, Jin T. FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. CNS Neurosci Ther. 2023.
Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, et al. Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases. J Clin Invest. 2019.
Li M, Wang Y, Zhang J, Cao Z, Wang S, Zheng W, Li Q, Zheng T, Wang X, Xu Q, et al. Culture of pyramidal neural precursors, neural stem cells, and fibroblasts on various biomaterials. J Biomater Sci Polym Ed. 2018:1-38.
Chen ZG, Y Zhang A. Cell therapy for macular degeneration-first phase I/II pluripotent stem cell-based clinical trial shows promise. Sci China Life Sci. 2014.
Guan Y, Wang R, Li X, Zou H, Yu W, Liang Z, Li L, Chen L, Zhou L, Chen ZG. Astrocytes constitute the major TNF-α-producing cell population in the infarct cortex in dMCAO rats receiving intravenous MSC infusion. Biomed Pharmacother. 2021;142:111971.